| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Gastrointestinal Imaging |
1 From the Department of Radiology and Center for Imaging Science, Sungkyunkwan University School of Medicine, 50 Ilwon-Dong, Kangnam-Ku, Seoul 135-710, Korea. Received November 14, 2001; revision requested January 24, 2002; revision received March 5; accepted April 16. Address correspondence to J.H.L. (e-mail: jhlim@smc.samsung.co.kr).
PURPOSE: To compare ferumoxides-enhanced magnetic resonance (MR) imaging with triple-phase helical computed tomography (CT) for the preoperative depiction of hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Seventy consecutive patients with a total of 79 HCC nodules underwent ferumoxides-enhanced MR imaging and triple-phase helical CT before surgery. The diagnosis of HCC was established by means of pathologic examination after surgical resection in all patients. MR images obtained with all sequences and triple-phase helical CT images were reviewed independently by three radiologists on a segment-by-segment basis. Accuracy for diagnosis of HCC was assessed by applying receiver operating characteristic (ROC) analysis to observations of 78 hepatic segments with at least one HCC nodule and 70 segments without HCC.
RESULTS: The diagnostic accuracy of findings at ferumoxides-enhanced MR imaging (with mean area-under-the-ROC-curve [Az] values for the three observers of 0.986, 0.979, and 0.980) was significantly higher (P < .001) than that of findings at triple-phase helical CT (with mean Az values for the three observers of 0.945, 0.948, and 0.964). The mean sensitivity of MR imaging (95%, 222 of 234 segments) was also significantly higher than that of triple-phase helical CT (88%, 205 of 234 segments) (P = .001, McNemar test). The mean specificity was 97% (261 of 270 segments) for MR imaging and 98% (264 of 270 segments) for CT, but this difference was not significant (P = .754, McNemar test).
CONCLUSION: Ferumoxides-enhanced MR imaging is superior to triple-phase helical CT for the preoperative depiction of HCC.
© RSNA, 2003
Index terms: Computed tomography (CT), phase imaging, 761.12114 • Iron • Liver neoplasms, CT, 761.12114 • Liver neoplasms, MR, 761.12143 • Magnetic resonance (MR), contrast media, 761.12143 • Receiver operating characteristic (ROC) curve
This article has been cited by other articles:
|
|
 |
|
  S. J. Kim, J. M. Lee, J. K. Han, K. H. Kim, J. Y. Lee, and B. I. Choi Peripheral Mass Forming Cholangiocarcinoma in Cirrhotic Liver Am. J. Roentgenol., December 1, 2007; 189(6): 1428 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. K. Kim, H. S. Kwak, C. S. Kim, G. H. Chung, Y. M. Han, and J. M. Lee Hepatocellular Carcinoma in Patients with Chronic Liver Disease: Comparison of SPIO-enhanced MR Imaging and 16-Detector Row CT Radiology, December 21, 2005; (2005) 2381042193. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Lutz, J. K. Willmann, K. Goepfert, B. Marincek, and D. Weishaupt Hepatocellular Carcinoma in Cirrhosis: Enhancement Patterns at Dynamic Gadolinium- and Superparamagnetic Iron Oxide-enhanced T1-weighted MR Imaging Radiology, November 1, 2005; 237(2): 520 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Kim, D. Choi, S. H. Kim, J. H. Lim, W. J. Lee, M. J. Kim, H. K. Lim, and S. J. Lee Ferucarbotran-Enhanced MRI Versus Triple-Phase MDCT for the Preoperative Detection of Hepatocellular Carcinoma Am. J. Roentgenol., April 1, 2005; 184(4): 1069 - 1076. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
